GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence

To provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process. The study design and se...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of clinical epidemiology Ročník 111; s. 105 - 114
Hlavní autori:	Schünemann, Holger J., Cuello, Carlos, Akl, Elie A., Mustafa, Reem A., Meerpohl, Jörg J., Thayer, Kris, Morgan, Rebecca L., Gartlehner, Gerald, Kunz, Regina, Katikireddi, S Vittal, Sterne, Jonathan, Higgins, Julian PT, Guyatt, Gordon
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 01.07.2019 Elsevier Limited
Predmet:	Bias Certainty of the evidence Clinical trials Clinical Trials as Topic - standards Decision making Design Domains Dose-response effects Epidemiology Evidence-Based Medicine - methods Evidence-Based Medicine - standards GRADE Humans Internal Medicine Nonrandomized studies Observational Studies as Topic - standards Practice Guidelines as Topic - standards Quality Quality of evidence Risk Assessment Risk Factors Risk of bias ROBINS Studies Systematic Reviews as Topic Technology assessment Uncertainty Working groups GRADE Risk of bias ROBINS Quality of evidence Nonrandomized studies Certainty of the evidence
ISSN:	0895-4356, 1878-5921, 1878-5921
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	To provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process. The study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group. We describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I. The use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment.
AbstractList	ObjectiveTo provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process.Study Design and SettingThe study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group.ResultsWe describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I.ConclusionsThe use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment. To provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process. The study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group. We describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I. The use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment. AbstractObjectiveTo provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process. Study Design and SettingThe study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group. ResultsWe describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I. ConclusionsThe use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment. To provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process.OBJECTIVETo provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk of bias in nonrandomized studies of interventions (ROBINS-I) tool as a part of GRADE's certainty rating process.The study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group.STUDY DESIGN AND SETTINGThe study design and setting comprised iterative discussions, testing in systematic reviews, and presentation at GRADE working group meetings with feedback from the GRADE working group.We describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I.RESULTSWe describe where to start the initial assessment of a body of evidence with the use of ROBINS-I and where one would anticipate the final rating would end up. The GRADE accounted for issues that mitigate concerns about confounding and selection bias by introducing the upgrading domains: large effects, dose-effect relations, and when plausible residual confounders or other biases increase certainty. They will need to be considered in an assessment of a body of evidence when using ROBINS-I.The use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment.CONCLUSIONSThe use of ROBINS-I in GRADE assessments may allow for a better comparison of evidence from randomized controlled trials (RCTs) and nonrandomized studies (NRSs) because they are placed on a common metric for risk of bias. Challenges remain, including appropriate presentation of evidence from RCTs and NRSs for decision-making and how to optimally integrate RCTs and NRSs in an evidence assessment.
Author	Gartlehner, Gerald Guyatt, Gordon Mustafa, Reem A. Thayer, Kris Katikireddi, S Vittal Sterne, Jonathan Meerpohl, Jörg J. Higgins, Julian PT Cuello, Carlos Akl, Elie A. Schünemann, Holger J. Kunz, Regina Morgan, Rebecca L.
Author_xml	– sequence: 1 givenname: Holger J. surname: Schünemann fullname: Schünemann, Holger J. email: schuneh@mcmaster.ca organization: Department of Health Research Methods, Evidence, and Impact and McGRADE Center, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4K1, Canada – sequence: 2 givenname: Carlos orcidid: 0000-0002-1742-0242 surname: Cuello fullname: Cuello, Carlos organization: Department of Health Research Methods, Evidence, and Impact and McGRADE Center, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4K1, Canada – sequence: 3 givenname: Elie A. orcidid: 0000-0002-3444-8618 surname: Akl fullname: Akl, Elie A. organization: Department of Health Research Methods, Evidence, and Impact and McGRADE Center, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4K1, Canada – sequence: 4 givenname: Reem A. surname: Mustafa fullname: Mustafa, Reem A. organization: Department of Health Research Methods, Evidence, and Impact and McGRADE Center, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4K1, Canada – sequence: 5 givenname: Jörg J. orcidid: 0000-0002-1333-5403 surname: Meerpohl fullname: Meerpohl, Jörg J. organization: Cochrane Germany, Medical Center University of Freiburg, Breisacher Strasse 153, Freiburg, 79110, Germany – sequence: 6 givenname: Kris surname: Thayer fullname: Thayer, Kris organization: Integrated Risk Information System (IRIS) Division, National Center for Environmental Assessment, Environmental Protection Agency, 1200 Pennsylvania Avenue, N.W.Washington, DC 20460, USA – sequence: 7 givenname: Rebecca L. surname: Morgan fullname: Morgan, Rebecca L. organization: Department of Health Research Methods, Evidence, and Impact and McGRADE Center, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4K1, Canada – sequence: 8 givenname: Gerald surname: Gartlehner fullname: Gartlehner, Gerald organization: Department for Evidence-Based Medicine and Clinical Epidemiology, Danube University Krems, Dr Karl Dorrek Straße 30, Krems, 3500, Austria – sequence: 9 givenname: Regina surname: Kunz fullname: Kunz, Regina organization: Basel Institute of Clinical Epidemiology, University Hospital Basel, Hebelstrasse 10, Basel, 4031, Switzerland – sequence: 10 givenname: S Vittal orcidid: 0000-0001-6593-9092 surname: Katikireddi fullname: Katikireddi, S Vittal organization: MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Top Floor, 200 Renfield Street, Glasgow, G2 3QB, Scotland – sequence: 11 givenname: Jonathan orcidid: 0000-0001-8496-6053 surname: Sterne fullname: Sterne, Jonathan organization: Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK – sequence: 12 givenname: Julian PT surname: Higgins fullname: Higgins, Julian PT organization: Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK – sequence: 13 givenname: Gordon surname: Guyatt fullname: Guyatt, Gordon organization: Department of Health Research Methods, Evidence, and Impact and McGRADE Center, McMaster University, 1280 Main Street West, Hamilton, Ontario, L8S4K1, Canada
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/29432858$$D View this record in MEDLINE/PubMed
BookMark	eNqNkt1u1DAQhSNURH_gFSpL3HCTxT-xkyCEKKW0K1VUauHacuIJ9TYbLx6naHkX3hWH7XKxFxTJsi3rnM-jM3OY7Q1-gCw7ZnTGKFOvF7NF27sBVm7GKatmlKXFn2QHrCqrXNac7WUHtKplXgip9rNDxAWlrKSlfJbt87oQvJLVQfbr_Prk4xn5NjoLEw_fkEQjF_4Hub76MP98k8-JGSzx8RYCid73mHZiEAGRBId3xHekcQaJG0gqMiS1X7qfYAnG0TpAgrd-7C1pgIyYnpM9mAgkEUkLIRo3xPVEMaTx9s8N7lM5QwvPs6ed6RFePJxH2ddPZ19OL_LLq_P56cll3kpZxFxIqbiRtRBQgwFZcgGMcVvwxoJUDROdEpKrrraG005KYWrbgKVtpTorQRxlrzbcVfDfR8Colw5b6HszgB9R8xRdzagqiyR9uSNd-DEMqTrNuVCsKAqlkur4QTU2S7B6FdzShLXeBp8EbzeCNnjEAJ1uXTTR-SEG43rNqJ76rBd622c99VlTlhZPdrVj3_7wqPH9xggpznsHQWPrpqitC9BGbb17HPFuBzGpXGv6O1gD_o2DaeSa6ptpCqchZKVgVLDi34D_qeA3vODvTg
CitedBy_id	crossref_primary_10_1080_10903127_2023_2232453 crossref_primary_10_1080_10408398_2023_2251583 crossref_primary_10_1016_j_amj_2024_05_002 crossref_primary_10_1186_s13643_020_01291_z crossref_primary_10_1007_s00464_024_11382_w crossref_primary_10_1371_journal_pone_0324167 crossref_primary_10_1146_annurev_statistics_040722_052011 crossref_primary_10_1038_s41432_024_01036_0 crossref_primary_10_1080_09638288_2024_2412185 crossref_primary_10_1002_14651858_CD013600_pub6 crossref_primary_10_1182_bloodadvances_2020002195 crossref_primary_10_1007_s00586_022_07463_w crossref_primary_10_1111_jep_13016 crossref_primary_10_1136_bmjsrh_2023_201792 crossref_primary_10_1186_s12890_021_01429_2 crossref_primary_10_1016_j_clinph_2020_03_024 crossref_primary_10_1186_s42358_025_00449_4 crossref_primary_10_1038_s41398_023_02620_1 crossref_primary_10_1002_psp4_13308 crossref_primary_10_1016_j_ebiom_2021_103633 crossref_primary_10_1016_j_vaccine_2023_11_005 crossref_primary_10_1111_cdoe_12999 crossref_primary_10_1111_clr_14427 crossref_primary_10_3389_fcimb_2025_1627206 crossref_primary_10_3389_fbioe_2019_00450 crossref_primary_10_1007_s40265_019_01182_1 crossref_primary_10_1016_j_amj_2023_11_005 crossref_primary_10_1016_j_advnut_2025_100453 crossref_primary_10_1542_peds_2020_0586 crossref_primary_10_1186_s12890_019_0963_y crossref_primary_10_1097_PRS_0000000000011734 crossref_primary_10_1146_annurev_publhealth_051920_114020 crossref_primary_10_1002_14651858_CD014871_pub2 crossref_primary_10_3390_jcm13092461 crossref_primary_10_1016_j_jclinepi_2024_111532 crossref_primary_10_1038_s41582_022_00733_7 crossref_primary_10_1016_j_jmir_2020_01_007 crossref_primary_10_1007_s44217_025_00559_7 crossref_primary_10_1186_s11556_025_00370_1 crossref_primary_10_3390_jcm12020446 crossref_primary_10_3390_metabo11110726 crossref_primary_10_1007_s00228_024_03797_0 crossref_primary_10_1159_000536660 crossref_primary_10_1080_09638288_2024_2349761 crossref_primary_10_1111_apt_16335 crossref_primary_10_1016_j_jclinepi_2021_02_010 crossref_primary_10_1186_s13034_022_00546_y crossref_primary_10_1002_rmv_70020 crossref_primary_10_1097_PEC_0000000000002488 crossref_primary_10_1155_2021_9963038 crossref_primary_10_1186_s13643_019_1220_4 crossref_primary_10_1136_heartjnl_2024_324685 crossref_primary_10_1136_bmjgh_2020_004166 crossref_primary_10_1177_21925682251343524 crossref_primary_10_1161_CIR_0000000000000891 crossref_primary_10_1002_14651858_CD015532 crossref_primary_10_1016_j_jclinepi_2022_04_013 crossref_primary_10_1007_s40264_022_01231_x crossref_primary_10_1155_2024_9769772 crossref_primary_10_1111_aogs_15061 crossref_primary_10_7759_cureus_84289 crossref_primary_10_1111_1471_0528_17320 crossref_primary_10_1016_j_jclinepi_2019_11_019 crossref_primary_10_1016_j_ajodo_2021_09_009 crossref_primary_10_1186_s12885_021_08258_w crossref_primary_10_1093_ntr_ntae206 crossref_primary_10_1016_j_jclinepi_2023_06_010 crossref_primary_10_1038_s41416_024_02857_7 crossref_primary_10_1177_20552076231191050 crossref_primary_10_1007_s00198_023_06709_7 crossref_primary_10_1016_j_advnut_2024_100249 crossref_primary_10_1016_j_jclinepi_2021_08_022 crossref_primary_10_1016_j_jvs_2025_01_234 crossref_primary_10_1007_s10639_024_12707_x crossref_primary_10_1007_s00423_022_02637_y crossref_primary_10_1016_j_resuscitation_2020_09_011 crossref_primary_10_1111_all_14575 crossref_primary_10_1097_CRD_0000000000001050 crossref_primary_10_1016_j_ultrasmedbio_2023_04_013 crossref_primary_10_1016_j_jocn_2025_111623 crossref_primary_10_1186_s13643_022_02106_z crossref_primary_10_1093_eurheartj_ehad340 crossref_primary_10_3389_fped_2021_660173 crossref_primary_10_1093_ptj_pzac154 crossref_primary_10_1016_j_advnut_2025_100413 crossref_primary_10_1007_s00330_021_07873_2 crossref_primary_10_1016_j_igie_2024_10_001 crossref_primary_10_1136_bmjopen_2018_024618 crossref_primary_10_1016_j_advnut_2025_100414 crossref_primary_10_1016_j_spinee_2024_11_015 crossref_primary_10_1136_bmjopen_2021_054282 crossref_primary_10_1210_clinem_dgaf262 crossref_primary_10_2337_dc22_1018 crossref_primary_10_1007_s10029_024_03119_4 crossref_primary_10_1038_s41598_023_34692_w crossref_primary_10_1097_SLA_0000000000006339 crossref_primary_10_1136_jnis_2024_023021 crossref_primary_10_1111_1471_0528_16324 crossref_primary_10_29219_fnr_v67_8961 crossref_primary_10_26633_RPSP_2022_65 crossref_primary_10_1111_jerd_12841 crossref_primary_10_3390_nu14204340 crossref_primary_10_1016_j_scitotenv_2021_150437 crossref_primary_10_3390_jcm9123806 crossref_primary_10_1002_14651858_CD015551_pub2 crossref_primary_10_1016_j_clnu_2025_04_013 crossref_primary_10_1007_s00394_025_03744_4 crossref_primary_10_1007_s00125_023_05928_1 crossref_primary_10_1016_j_ienj_2022_101173 crossref_primary_10_1016_j_ajcnut_2023_07_012 crossref_primary_10_1016_j_resplu_2024_100828 crossref_primary_10_1002_hsr2_255 crossref_primary_10_1016_j_avsg_2025_08_037 crossref_primary_10_3389_froh_2023_1110634 crossref_primary_10_1016_j_drugalcdep_2025_112632 crossref_primary_10_1111_codi_16118 crossref_primary_10_1016_j_jcrc_2024_154844 crossref_primary_10_3389_fonc_2022_907377 crossref_primary_10_1136_openhrt_2023_002501 crossref_primary_10_1016_j_envint_2025_109462 crossref_primary_10_1136_bmj_2024_083864 crossref_primary_10_3389_fonc_2020_608282 crossref_primary_10_1089_thy_2020_0459 crossref_primary_10_1093_ehjcvp_pvaa138 crossref_primary_10_1007_s12028_023_01713_5 crossref_primary_10_1007_s00394_021_02789_5 crossref_primary_10_1016_j_ajpc_2024_100868 crossref_primary_10_1089_bfm_2023_0158 crossref_primary_10_3390_jcm11092570 crossref_primary_10_1136_bmjopen_2021_050296 crossref_primary_10_2337_dci23_0031 crossref_primary_10_1097_MD_0000000000028709 crossref_primary_10_1186_s12966_024_01593_8 crossref_primary_10_3389_fonc_2022_1025855 crossref_primary_10_1097_ACO_0000000000000815 crossref_primary_10_1186_s12966_023_01542_x crossref_primary_10_1007_s00120_021_01493_w crossref_primary_10_1111_joor_13780 crossref_primary_10_1186_s12874_022_01701_x crossref_primary_10_1007_s00192_023_05569_3 crossref_primary_10_1097_MCG_0000000000001668 crossref_primary_10_1177_13623613241255302 crossref_primary_10_1002_gin2_70028 crossref_primary_10_1111_clr_13291 crossref_primary_10_1111_papr_13423 crossref_primary_10_1007_s00394_023_03143_7 crossref_primary_10_1002_jrsm_1730 crossref_primary_10_1111_1468_0009_12689 crossref_primary_10_1186_s13643_022_02159_0 crossref_primary_10_1080_10408398_2024_2317877 crossref_primary_10_1002_uog_20131 crossref_primary_10_1016_j_ssaho_2025_101299 crossref_primary_10_1136_bmj_2021_067516 crossref_primary_10_1016_j_aap_2021_105970 crossref_primary_10_1089_dtom_2025_0022 crossref_primary_10_1016_j_jclinepi_2022_10_010 crossref_primary_10_1111_cea_13797 crossref_primary_10_1002_rmv_2329 crossref_primary_10_1007_s13304_023_01737_8 crossref_primary_10_1016_j_jclinepi_2022_02_011 crossref_primary_10_1007_s00210_025_04482_4 crossref_primary_10_31354_globalce_v7i1_206 crossref_primary_10_3390_nu13113748 crossref_primary_10_1111_clr_13279 crossref_primary_10_1016_j_imr_2020_100452 crossref_primary_10_1016_j_msard_2021_103279 crossref_primary_10_3390_jcm11051448 crossref_primary_10_1177_1558944720974363 crossref_primary_10_3389_frma_2021_675071 crossref_primary_10_1016_j_apmr_2022_09_005 crossref_primary_10_1177_23821205241303560 crossref_primary_10_1186_s12879_020_4824_3 crossref_primary_10_3390_ijerph18179080 crossref_primary_10_1007_s00384_025_04807_y crossref_primary_10_1177_10556656221136325 crossref_primary_10_1007_s00592_022_01850_x crossref_primary_10_1007_s00125_021_05458_8 crossref_primary_10_1002_14651858_CD015530_pub2 crossref_primary_10_1111_jocn_17832 crossref_primary_10_2196_53187 crossref_primary_10_3389_fpsyg_2023_1173425 crossref_primary_10_1097_DCC_0000000000000597 crossref_primary_10_1111_iej_13726 crossref_primary_10_3389_fphys_2025_1625516 crossref_primary_10_1002_fsn3_2781 crossref_primary_10_1016_j_amj_2025_04_005 crossref_primary_10_1093_ejo_cjad011 crossref_primary_10_3390_ijerph18126187 crossref_primary_10_1177_21514593251350490 crossref_primary_10_1016_j_jclinepi_2023_04_001 crossref_primary_10_1111_jcpe_13529 crossref_primary_10_1136_bmjebm_2024_112868 crossref_primary_10_3390_jcm12165418 crossref_primary_10_1002_rmv_2331 crossref_primary_10_1002_rmv_2332 crossref_primary_10_1016_j_cdnut_2024_102159 crossref_primary_10_1002_rmv_2330 crossref_primary_10_1186_s13018_025_05725_z crossref_primary_10_2105_AJPH_2021_306658 crossref_primary_10_1136_bmjopen_2019_035517 crossref_primary_10_1177_27551938241255041 crossref_primary_10_1177_00048674221086498 crossref_primary_10_1177_1362361319877337 crossref_primary_10_1007_s00464_022_09625_9 crossref_primary_10_1016_j_avsg_2024_08_028 crossref_primary_10_1186_s13643_020_01462_y crossref_primary_10_1371_journal_pone_0306885 crossref_primary_10_1016_j_jclinepi_2022_02_009 crossref_primary_10_1097_SLA_0000000000005531 crossref_primary_10_1001_jamapediatrics_2025_0689 crossref_primary_10_1016_j_jpedsurg_2022_03_022 crossref_primary_10_1007_s00120_021_01471_2 crossref_primary_10_1186_s13643_023_02199_0 crossref_primary_10_1371_journal_pone_0289538 crossref_primary_10_1080_17437199_2020_1858926 crossref_primary_10_1016_j_envres_2020_109561 crossref_primary_10_1080_17483107_2024_2316293 crossref_primary_10_1080_0886022X_2023_2169618 crossref_primary_10_1093_ejo_cjad009 crossref_primary_10_1016_j_jphys_2023_05_012 crossref_primary_10_11124_JBIES_23_00463 crossref_primary_10_1016_j_ejca_2025_115669 crossref_primary_10_1016_j_shpsa_2020_10_008 crossref_primary_10_1111_dme_15099 crossref_primary_10_1016_j_jclinepi_2021_01_001 crossref_primary_10_1038_s41433_024_02937_1 crossref_primary_10_1093_aje_kwae332 crossref_primary_10_1136_bmjebm_2022_112111 crossref_primary_10_1002_ppul_24605 crossref_primary_10_1016_j_envint_2022_107109 crossref_primary_10_1016_S2352_4642_23_00078_0 crossref_primary_10_1080_19390211_2025_2490659 crossref_primary_10_12674_ptk_2025_32_2_91 crossref_primary_10_5867_medwave_2020_06_7978 crossref_primary_10_1136_bmjopen_2025_101084 crossref_primary_10_1007_s00167_021_06692_8 crossref_primary_10_1136_bmjgh_2019_002128 crossref_primary_10_1111_edt_12564 crossref_primary_10_1136_bmj_n1864 crossref_primary_10_1183_23120541_00976_2020 crossref_primary_10_1080_14779072_2021_1920926 crossref_primary_10_1007_s00784_022_04383_3 crossref_primary_10_1016_j_envint_2021_107032 crossref_primary_10_1016_j_jadohealth_2021_08_010 crossref_primary_10_1136_bmjebm_2022_112002 crossref_primary_10_1016_j_zefq_2021_05_003 crossref_primary_10_14309_ctg_0000000000000275 crossref_primary_10_3390_jpm12122058 crossref_primary_10_1016_j_advnut_2025_100391 crossref_primary_10_1186_s12889_022_14841_y crossref_primary_10_1016_j_jclinepi_2020_09_033 crossref_primary_10_7326_M23_1626 crossref_primary_10_1002_14651858_CD013521_pub2 crossref_primary_10_1007_s00394_024_03380_4 crossref_primary_10_1016_j_ejogrb_2022_10_004 crossref_primary_10_5867_medwave_2020_06_7966 crossref_primary_10_1002_14651858_CD015932_pub2 crossref_primary_10_1016_j_cegh_2023_101484 crossref_primary_10_1186_s40510_020_00334_4 crossref_primary_10_3324_haematol_2023_284281 crossref_primary_10_1136_bjsports_2023_107336 crossref_primary_10_1002_jrsm_1313 crossref_primary_10_1016_j_cmi_2020_11_006 crossref_primary_10_1136_bmjgh_2018_000716 crossref_primary_10_1177_17479541241283442 crossref_primary_10_1007_s11739_024_03736_y crossref_primary_10_1007_s00520_019_05255_5 crossref_primary_10_1002_14651858_CD015383_pub2 crossref_primary_10_1093_ajcn_nqab002 crossref_primary_10_1016_j_jhsa_2023_10_011 crossref_primary_10_1093_advances_nmac088 crossref_primary_10_1093_ajcn_nqab124 crossref_primary_10_1111_jopr_14064 crossref_primary_10_1016_j_ijheh_2025_114670 crossref_primary_10_1136_bmjnph_2021_000410 crossref_primary_10_1016_j_amj_2023_07_003 crossref_primary_10_1055_a_2591_6995 crossref_primary_10_1186_s13643_022_01892_w crossref_primary_10_3390_jcm13123621 crossref_primary_10_1186_s12903_025_06348_w crossref_primary_10_1136_bmjopen_2021_058293 crossref_primary_10_1093_nutrit_nuaf030 crossref_primary_10_1245_s10434_025_17421_7 crossref_primary_10_1136_archdischild_2024_327909 crossref_primary_10_1186_s13643_020_01406_6 crossref_primary_10_1183_13993003_01967_2019 crossref_primary_10_1136_bmjopen_2022_062951 crossref_primary_10_1136_bmjopen_2023_082961 crossref_primary_10_1186_s12940_024_01069_z crossref_primary_10_1111_jcpe_13052 crossref_primary_10_1186_s40729_023_00476_0 crossref_primary_10_3390_ijerph191911943 crossref_primary_10_1097_DCR_0000000000003766 crossref_primary_10_1016_j_amsu_2020_11_060 crossref_primary_10_1016_j_chest_2021_02_020 crossref_primary_10_1136_bmjopen_2019_035443 crossref_primary_10_1016_j_bja_2019_08_015 crossref_primary_10_1111_jocn_16815 crossref_primary_10_3390_antibiotics10060697 crossref_primary_10_1007_s40263_024_01131_x crossref_primary_10_1016_j_envint_2024_109003 crossref_primary_10_1002_brb3_70246 crossref_primary_10_1016_j_jvsv_2022_10_005 crossref_primary_10_1136_bmjopen_2020_045841 crossref_primary_10_1186_s12902_025_01852_0 crossref_primary_10_1186_s13034_023_00612_z crossref_primary_10_1016_j_clinthera_2023_09_010 crossref_primary_10_1186_s12874_022_01715_5 crossref_primary_10_1371_journal_pone_0249087 crossref_primary_10_1186_s13643_022_01937_0 crossref_primary_10_3390_ijerph22060822 crossref_primary_10_1161_STROKEAHA_120_028798 crossref_primary_10_1093_nutrit_nuaf013 crossref_primary_10_1007_s11606_019_05502_9 crossref_primary_10_1080_10408398_2021_1975092 crossref_primary_10_4103_bjhs_bjhs_17_24 crossref_primary_10_1016_j_numecd_2023_07_004 crossref_primary_10_1186_s12916_022_02369_2 crossref_primary_10_1186_s43088_023_00431_3 crossref_primary_10_1136_bmjopen_2020_044763 crossref_primary_10_3390_biomedicines13010182 crossref_primary_10_1002_jrsm_1582 crossref_primary_10_1111_jre_12663 crossref_primary_10_3390_nu13103303 crossref_primary_10_1097_AUD_0000000000001374 crossref_primary_10_1186_s12889_019_8033_1 crossref_primary_10_1080_17512433_2022_2121705 crossref_primary_10_1007_s00590_023_03781_x crossref_primary_10_1016_j_puhe_2025_01_040 crossref_primary_10_1136_bmjopen_2020_043961 crossref_primary_10_7759_cureus_11386 crossref_primary_10_1111_jcpe_13487 crossref_primary_10_1177_15347354231198074 crossref_primary_10_1177_21925682231181875 crossref_primary_10_1016_j_ajic_2022_02_018 crossref_primary_10_1111_jcmm_17457 crossref_primary_10_1016_j_scitotenv_2023_164435 crossref_primary_10_1177_02692155251362719 crossref_primary_10_2105_AJPH_2020_306091 crossref_primary_10_1111_jgh_16846 crossref_primary_10_1136_bmjopen_2022_062405 crossref_primary_10_1007_s00125_022_05803_5 crossref_primary_10_1155_2024_5586202 crossref_primary_10_1007_s12028_021_01375_1 crossref_primary_10_1038_s41440_023_01260_8 crossref_primary_10_1080_09638288_2023_2207043 crossref_primary_10_1016_j_jpedsurg_2020_03_025 crossref_primary_10_1111_all_16195 crossref_primary_10_1111_bju_15823 crossref_primary_10_1111_wrr_13061 crossref_primary_10_12688_hrbopenres_14087_1 crossref_primary_10_1016_j_jclinepi_2021_04_017 crossref_primary_10_1007_s40122_021_00269_6 crossref_primary_10_3389_fneur_2025_1567708 crossref_primary_10_1136_bmjopen_2020_043613 crossref_primary_10_1093_nutrit_nuae033 crossref_primary_10_1111_jan_17093 crossref_primary_10_1007_s00464_022_09090_4 crossref_primary_10_1111_acem_14882 crossref_primary_10_1136_bmjopen_2021_052777 crossref_primary_10_3390_jfb14080411 crossref_primary_10_1097_BCO_0000000000000884 crossref_primary_10_3390_nu15143151 crossref_primary_10_1002_14651858_CD013764_pub2 crossref_primary_10_1111_crj_13798 crossref_primary_10_1016_j_advnut_2023_05_008 crossref_primary_10_1016_j_ijsu_2021_106021 crossref_primary_10_1186_s13643_019_1064_y crossref_primary_10_1136_bmjgh_2018_000848 crossref_primary_10_1016_j_tmrv_2025_150929 crossref_primary_10_1016_S1474_4422_25_00227_3 crossref_primary_10_3389_fneur_2022_1036891 crossref_primary_10_1177_13623613251372276 crossref_primary_10_1080_10669817_2024_2408500 crossref_primary_10_1080_14796678_2025_2509368 crossref_primary_10_1093_nutrit_nuae135 crossref_primary_10_1016_j_jvs_2025_07_050 crossref_primary_10_3390_nursrep15020032 crossref_primary_10_1016_j_jclinepi_2023_02_008 crossref_primary_10_1093_rap_rkae027 crossref_primary_10_1097_PRS_0000000000005881 crossref_primary_10_1186_s13012_020_00984_2 crossref_primary_10_1016_j_numecd_2025_104220 crossref_primary_10_4187_respcare_11170 crossref_primary_10_1016_j_psychres_2019_112556 crossref_primary_10_21307_aoj_2021_004 crossref_primary_10_23736_S1973_9087_23_08031_0 crossref_primary_10_1016_j_envint_2021_106868 crossref_primary_10_1186_s13643_024_02464_w crossref_primary_10_1177_02692163241286658 crossref_primary_10_1016_j_brainres_2022_148190 crossref_primary_10_1016_j_advnut_2022_10_009 crossref_primary_10_1186_s13643_020_1283_2 crossref_primary_10_1002_ajh_27288 crossref_primary_10_1111_acer_14508 crossref_primary_10_1016_j_jclinepi_2022_09_014 crossref_primary_10_1123_kr_2024_0023 crossref_primary_10_1093_nutrit_nuad029 crossref_primary_10_4103_ds_DS_D_22_00154 crossref_primary_10_1002_14651858_CD016121 crossref_primary_10_1177_15266028241252730 crossref_primary_10_1016_j_burns_2021_10_007 crossref_primary_10_1093_heapol_czad058 crossref_primary_10_1111_ene_16527 crossref_primary_10_1007_s00402_022_04603_1 crossref_primary_10_1016_S2468_2667_24_00097_5 crossref_primary_10_1136_bmjnph_2023_000832 crossref_primary_10_4193_Rhin21_274 crossref_primary_10_7326_ANNALS_24_03495 crossref_primary_10_1136_bmjnph_2023_000835 crossref_primary_10_1016_j_preghy_2023_11_003 crossref_primary_10_1016_j_ejogrb_2020_07_020 crossref_primary_10_1542_peds_2021_055067 crossref_primary_10_1136_bmjopen_2023_073397 crossref_primary_10_1002_hed_26803 crossref_primary_10_1111_aogs_13968 crossref_primary_10_1016_j_jclinepi_2021_11_026 crossref_primary_10_1177_17562872211053679 crossref_primary_10_1136_bmjopen_2018_028242 crossref_primary_10_1016_j_wneu_2022_10_083 crossref_primary_10_1136_bmjopen_2023_074494 crossref_primary_10_1136_bmjopen_2020_037324 crossref_primary_10_3389_fendo_2025_1555186 crossref_primary_10_1016_j_advnut_2024_100211 crossref_primary_10_1136_bmjnph_2021_000248 crossref_primary_10_1007_s00198_023_06948_8 crossref_primary_10_1016_j_nedt_2025_106725 crossref_primary_10_1111_jgh_15401 crossref_primary_10_1007_s00467_023_06139_x crossref_primary_10_1186_s13643_020_1271_6 crossref_primary_10_1016_j_chemosphere_2020_126984 crossref_primary_10_1016_j_metabol_2025_156303 crossref_primary_10_1186_s12889_025_22434_8 crossref_primary_10_1136_jech_2023_220781 crossref_primary_10_3389_fsurg_2022_1012897 crossref_primary_10_1016_j_jclinepi_2018_01_010 crossref_primary_10_1186_s12960_022_00755_8 crossref_primary_10_1007_s10926_019_09854_1 crossref_primary_10_3389_fpubh_2023_1215486 crossref_primary_10_1093_mr_roae050 crossref_primary_10_1007_s00394_020_02464_1 crossref_primary_10_1093_advances_nmac040 crossref_primary_10_1186_s13643_023_02259_5 crossref_primary_10_1007_s00394_023_03234_5 crossref_primary_10_1016_j_envint_2021_106828 crossref_primary_10_1093_mr_roae046 crossref_primary_10_1186_s12890_022_02072_1 crossref_primary_10_1016_j_jebdp_2022_101732 crossref_primary_10_1016_j_amjoto_2025_104707 crossref_primary_10_1007_s00520_022_06904_y crossref_primary_10_1186_s12891_022_06044_8 crossref_primary_10_1212_WNL_0000000000010851 crossref_primary_10_3389_fneur_2022_1061431 crossref_primary_10_1002_14651858_CD016207 crossref_primary_10_1016_j_spinee_2018_06_720 crossref_primary_10_1016_j_jdiacomp_2025_109060 crossref_primary_10_1136_bmjopen_2018_027298 crossref_primary_10_1093_ejo_cjz094 crossref_primary_10_1186_s13643_023_02225_1 crossref_primary_10_3390_dj13050213 crossref_primary_10_1515_med_2022_0605 crossref_primary_10_3171_2020_4_JNS20970 crossref_primary_10_1111_joor_13178 crossref_primary_10_1111_ner_13519 crossref_primary_10_1136_bmjopen_2021_057394 crossref_primary_10_1007_s40368_023_00854_7 crossref_primary_10_1016_j_hansur_2025_102129 crossref_primary_10_3390_ijerph21020205 crossref_primary_10_1002_ppul_26108 crossref_primary_10_1016_j_envint_2021_106972 crossref_primary_10_1016_j_ijcard_2025_133746 crossref_primary_10_1016_j_jdent_2024_105459 crossref_primary_10_1111_jan_14303 crossref_primary_10_1186_s13643_023_02326_x crossref_primary_10_1016_j_avsg_2025_04_107 crossref_primary_10_1016_j_smrv_2021_101532 crossref_primary_10_1136_bmjopen_2022_069771 crossref_primary_10_1002_lary_32296 crossref_primary_10_1097_DSS_0000000000003546 crossref_primary_10_1186_s13643_021_01684_8 crossref_primary_10_1007_s00384_024_04625_8 crossref_primary_10_1016_j_ejvs_2023_02_080 crossref_primary_10_1371_journal_pmed_1003347 crossref_primary_10_3390_vaccines12030261 crossref_primary_10_1053_j_gastro_2020_05_001 crossref_primary_10_1186_s12874_021_01224_x crossref_primary_10_1016_j_jcjo_2020_09_001 crossref_primary_10_1007_s00590_024_04030_5 crossref_primary_10_1177_22143602241289216 crossref_primary_10_1016_j_jclinepi_2023_09_011 crossref_primary_10_3389_fnhum_2025_1532783 crossref_primary_10_3390_nu16020324 crossref_primary_10_3389_fimmu_2022_940562 crossref_primary_10_1371_journal_pone_0275958 crossref_primary_10_1016_j_arr_2023_101997 crossref_primary_10_1002_14651858_CD013874_pub3 crossref_primary_10_1097_QAD_0000000000002337 crossref_primary_10_1016_j_eujim_2025_102511 crossref_primary_10_1111_aas_14497 crossref_primary_10_1016_j_chiabu_2022_105935 crossref_primary_10_1186_s13756_020_00863_x crossref_primary_10_1186_s12916_023_03093_1
Cites_doi	10.1371/journal.pmed.0040119 10.1136/bmj.39500.677199.AE 10.1136/jech-2014-204711 10.1136/bmj.i4919 10.1136/bmj.h870 10.1093/ije/dym018 10.1016/j.envint.2016.03.027 10.1016/j.jclinepi.2017.05.005 10.1146/annurev-publhealth-031816-044327 10.1093/pubmed/fds092 10.1016/j.jclinepi.2012.01.006 10.1016/j.jclinepi.2010.04.026 10.1016/j.jclinepi.2010.09.011 10.1136/bmj.328.7454.1490 10.1136/bmj.g5630 10.1016/j.jclinepi.2011.06.004 10.1016/j.jclinepi.2017.05.006 10.1016/j.jclinepi.2016.01.032 10.1136/bmj.e7401 10.1136/bmj.i2089 10.1016/j.envint.2016.01.004 10.1136/bmj.i2016
ContentType	Journal Article
Copyright	2018 Elsevier Inc. Elsevier Inc. Copyright © 2018 Elsevier Inc. All rights reserved. 2018. Elsevier Inc.
Copyright_xml	– notice: 2018 Elsevier Inc. – notice: Elsevier Inc. – notice: Copyright © 2018 Elsevier Inc. All rights reserved. – notice: 2018. Elsevier Inc.
CorporateAuthor	GRADE Working Group
CorporateAuthor_xml	– name: GRADE Working Group
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QP 7RV 7T2 7T7 7TK 7U7 7U9 7X7 7XB 88C 88E 8AO 8C1 8FD 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BENPR C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 K9. KB0 M0S M0T M1P M2O M7N MBDVC NAPCQ P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U 7X8
DOI	10.1016/j.jclinepi.2018.01.012
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials Environmental Sciences and Pollution Management ProQuest One Sustainability Health Research Premium Collection Health & Medical Research Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic Toxicology Abstracts ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Medical Library ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Research Library Prep MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1878-5921
EndPage	114
ExternalDocumentID	29432858 10_1016_j_jclinepi_2018_01_012 S0895435617310314 1_s2_0_S0895435617310314
Genre	Journal Article
GrantInformation_xml	– fundername: Chief Scientist Office grantid: SCAF/15/02 – fundername: Medical Research Council grantid: MC_UU_12017/15 – fundername: Medical Research Council grantid: MC_UU_12017/13 – fundername: Chief Scientist Office grantid: SPHSU15 – fundername: Chief Scientist Office grantid: SPHSU13 – fundername: Medical Research Council grantid: MR/M025209/1
GroupedDBID	--- --K --M -~X .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29K 4.4 457 4CK 4G. 53G 5GY 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8P~ 9JM 9JO AABNK AAEDT AAEDW AAFJI AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYJJ AAYWO ABBQC ABFNM ABIVO ABJNI ABLJU ABMAC ABMMH ABMZM ABOCM ABUWG ABWVN ABXDB ACDAQ ACGFS ACIEU ACIUM ACLOT ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AENEX AEUPX AEUYN AEVXI AFFNX AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOMHK APXCP AQUVI ASPBG AVARZ AVWKF AXJTR AZFZN AZQEC BENPR BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CS3 D-I DU5 DWQXO EBS EFJIC EFKBS EFLBG EJD EMOBN EO8 EO9 EP2 EP3 EX3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HEH HMCUK HMK HMO HVGLF HZ~ IHE J1W KOM L7B M0T M1P M29 M2O M3W M41 MO0 N9A NAPCQ O-L O9- OAUVE OD~ OHT OO0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PRBVW PROAC PSQYO Q38 R2- ROL RPZ SAE SCC SDF SDG SDP SEL SES SEW SPCBC SSB SSH SSO SSZ SV3 T5K UAP UKHRP WOW WUQ X7M XPP YHZ Z5R ZGI ~G- ~HD 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AJBFU AKYCK F3I LCYCR ZA5 9DU AAYXX AFFHD CITATION AGCQF AGRNS CGR CUY CVF ECM EIF NPM 7QL 7QP 7T2 7T7 7TK 7U7 7U9 7XB 8FD 8FK C1K FR3 H94 K9. M7N MBDVC P64 PKEHL PQEST PQUKI Q9U 7X8 PUEGO
ID	FETCH-LOGICAL-c554t-35562a5933e9eae5723e112d42bde56b13f63526f9da20f553a9dbed0c86fd5e3
IEDL.DBID	7X7
ISICitedReferencesCount	558
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000472124400012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0895-4356 1878-5921
IngestDate	Sun Sep 28 00:04:45 EDT 2025 Sat Nov 29 14:38:13 EST 2025 Mon Jul 21 06:05:38 EDT 2025 Sat Nov 29 04:51:40 EST 2025 Tue Nov 18 22:36:40 EST 2025 Fri Feb 23 02:32:17 EST 2024 Sun Feb 23 10:18:58 EST 2025 Tue Oct 14 19:36:02 EDT 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Keywords	GRADE Risk of bias ROBINS Quality of evidence Nonrandomized studies Certainty of the evidence
Language	English
License	Copyright © 2018 Elsevier Inc. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c554t-35562a5933e9eae5723e112d42bde56b13f63526f9da20f553a9dbed0c86fd5e3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23
ORCID	0000-0002-3444-8618 0000-0001-6593-9092 0000-0002-1333-5403 0000-0002-1742-0242 0000-0001-8496-6053
OpenAccessLink	https://research-information.bris.ac.uk/ws/files/164358214/GRADE_RoB_and_NRS_20171214_revised.pdf
PMID	29432858
PQID	2236144466
PQPubID	105585
PageCount	10
ParticipantIDs	proquest_miscellaneous_2001910674 proquest_journals_2236144466 pubmed_primary_29432858 crossref_citationtrail_10_1016_j_jclinepi_2018_01_012 crossref_primary_10_1016_j_jclinepi_2018_01_012 elsevier_sciencedirect_doi_10_1016_j_jclinepi_2018_01_012 elsevier_clinicalkeyesjournals_1_s2_0_S0895435617310314 elsevier_clinicalkey_doi_10_1016_j_jclinepi_2018_01_012
PublicationCentury	2000
PublicationDate	2019-07-01
PublicationDateYYYYMMDD	2019-07-01
PublicationDate_xml	– month: 07 year: 2019 text: 2019-07-01 day: 01
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: Elmsford
PublicationTitle	Journal of clinical epidemiology
PublicationTitleAlternate	J Clin Epidemiol
PublicationYear	2019
Publisher	Elsevier Inc Elsevier Limited
Publisher_xml	– name: Elsevier Inc – name: Elsevier Limited
References	Guyatt, Oxman, Sultan, Glasziou, Akl, Alonso-Coello (bib23) 2011; 64 Guyatt, Oxman, Akl, Kunz, Vist, Brozek (bib1) 2011; 64 Spencer, Iorio, You, Murad, Schunemann, Vandvik (bib6) 2012; 345 Alonso-Coello, Oxman, Moberg, Brignardello-Petersen, Akl, Davoli (bib9) 2016; 353 Puhan, Schunemann, Murad, Li, Brignardello-Petersen, Singh (bib3) 2014; 349 Schunemann, Mustafa, Brozek, Santesso, Alonso-Coello, Guyatt (bib11) 2016; 76 Devereaux, Choi, Lacchetti, Weaver, Schunemann, Haines (bib25) 2002; 166 Anderson, Higgins (bib18) 2007; 36 Atkins, Best, Briss, Eccles, Falck-Ytter, Flottorp (bib21) 2004; 328 Guyatt, Oxman, Schunemann, Tugwell, Knotterus (bib2) 2011; 64 Schunemann, Oxman, Brozek, Glasziou, Bossuyt, Chang (bib5) 2008; 149 Alonso-Coello, Schunemann, Moberg, Brignardello-Petersen, Akl, Davoli (bib10) 2016; 353 Schunemann, Best, Vist, Oxman, Group (bib4) 2003; 169 Guyatt, Ebrahim, Alonso-Coello, Johnston, Mathioudakis, Briel (bib16) 2017; 87 Craig, Katikireddi, Leyland, Popham (bib22) 2017; 38 Schunemann, Hill, Kakad, Vist, Bellamy, Stockman (bib14) 2007; 4 Morgan, Thayer, Bero, Bruce, Falck-Ytter, Ghersi (bib17) 2016; 92-93 Guyatt, Oxman, Sultan, Brozek, Glasziou, Alonso-Coello (bib8) 2013; 66 Hultcrantz, Rind, Akl, Treweek, Mustafa, Iorio (bib24) 2017; 87 Thayer, Schunemann (bib13) 2016; 92-93 Burford, Rehfuess, Schunemann, Akl, Waters, Armstrong (bib12) 2012; 34 Katikireddi, Egan, Petticrew (bib20) 2015; 69 Schunemann, Oxman, Brozek, Glasziou, Jaeschke, Vist (bib7) 2008; 336 Sterne, Hernan, Reeves, Savovic, Berkman, Viswanathan (bib19) 2016; 355 Iorio, Spencer, Falavigna, Alba, Lang, Burnand (bib15) 2015; 350 Schunemann (10.1016/j.jclinepi.2018.01.012_bib5) 2008; 149 Craig (10.1016/j.jclinepi.2018.01.012_bib22) 2017; 38 Guyatt (10.1016/j.jclinepi.2018.01.012_bib23) 2011; 64 Schunemann (10.1016/j.jclinepi.2018.01.012_bib4) 2003; 169 Alonso-Coello (10.1016/j.jclinepi.2018.01.012_bib9) 2016; 353 Morgan (10.1016/j.jclinepi.2018.01.012_bib17) 2016; 92-93 Schunemann (10.1016/j.jclinepi.2018.01.012_bib11) 2016; 76 Guyatt (10.1016/j.jclinepi.2018.01.012_bib2) 2011; 64 Spencer (10.1016/j.jclinepi.2018.01.012_bib6) 2012; 345 Burford (10.1016/j.jclinepi.2018.01.012_bib12) 2012; 34 Guyatt (10.1016/j.jclinepi.2018.01.012_bib8) 2013; 66 Schunemann (10.1016/j.jclinepi.2018.01.012_bib7) 2008; 336 Atkins (10.1016/j.jclinepi.2018.01.012_bib21) 2004; 328 Sterne (10.1016/j.jclinepi.2018.01.012_bib19) 2016; 355 Guyatt (10.1016/j.jclinepi.2018.01.012_bib1) 2011; 64 Guyatt (10.1016/j.jclinepi.2018.01.012_bib16) 2017; 87 Anderson (10.1016/j.jclinepi.2018.01.012_bib18) 2007; 36 Alonso-Coello (10.1016/j.jclinepi.2018.01.012_bib10) 2016; 353 Devereaux (10.1016/j.jclinepi.2018.01.012_bib25) 2002; 166 Iorio (10.1016/j.jclinepi.2018.01.012_bib15) 2015; 350 Thayer (10.1016/j.jclinepi.2018.01.012_bib13) 2016; 92-93 Katikireddi (10.1016/j.jclinepi.2018.01.012_bib20) 2015; 69 Schunemann (10.1016/j.jclinepi.2018.01.012_bib14) 2007; 4 Puhan (10.1016/j.jclinepi.2018.01.012_bib3) 2014; 349 Hultcrantz (10.1016/j.jclinepi.2018.01.012_bib24) 2017; 87
References_xml	– volume: 64 start-page: 383 year: 2011 end-page: 394 ident: bib1 article-title: GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables publication-title: J Clin Epidemiol – volume: 328 start-page: 1490 year: 2004 ident: bib21 article-title: Grading quality of evidence and strength of recommendations publication-title: BMJ – volume: 38 start-page: 39 year: 2017 end-page: 56 ident: bib22 article-title: Natural experiments: an overview of methods, approaches, and contributions to public health intervention research publication-title: Annu Rev Public Health – volume: 353 start-page: i2016 year: 2016 ident: bib10 article-title: GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction publication-title: BMJ – volume: 355 start-page: i4919 year: 2016 ident: bib19 article-title: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions publication-title: BMJ – volume: 353 start-page: i2089 year: 2016 ident: bib9 article-title: GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines publication-title: BMJ – volume: 350 start-page: h870 year: 2015 ident: bib15 article-title: Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients publication-title: BMJ – volume: 92-93 start-page: 611 year: 2016 end-page: 616 ident: bib17 article-title: GRADE: assessing the quality of evidence in environmental and occupational health publication-title: Environ Int – volume: 87 start-page: 14 year: 2017 end-page: 22 ident: bib16 article-title: GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence publication-title: J Clin Epidemiol – volume: 69 start-page: 189 year: 2015 end-page: 195 ident: bib20 article-title: How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study publication-title: J Epidemiol Community Health – volume: 166 start-page: 1399 year: 2002 end-page: 1406 ident: bib25 article-title: A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals publication-title: CMAJ – volume: 4 start-page: e119 year: 2007 ident: bib14 article-title: Transparent development of the WHO rapid advice guidelines publication-title: PLoS Med – volume: 336 start-page: 1106 year: 2008 end-page: 1110 ident: bib7 article-title: Grading quality of evidence and strength of recommendations for diagnostic tests and strategies publication-title: BMJ – volume: 349 start-page: g5630 year: 2014 ident: bib3 article-title: A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis publication-title: BMJ – volume: 87 start-page: 4 year: 2017 end-page: 13 ident: bib24 article-title: The GRADE Working Group clarifies the construct of certainty of evidence publication-title: J Clin Epidemiol – volume: 64 start-page: 1311 year: 2011 end-page: 1316 ident: bib23 article-title: GRADE guidelines: 9. Rating up the quality of evidence publication-title: J Clin Epidemiol – volume: 345 start-page: e7401 year: 2012 ident: bib6 article-title: Uncertainties in baseline risk estimates and confidence in treatment effects publication-title: BMJ – volume: 92-93 start-page: 585 year: 2016 end-page: 589 ident: bib13 article-title: Using GRADE to respond to health questions with different levels of urgency publication-title: Environ Int – volume: 76 start-page: 89 year: 2016 end-page: 98 ident: bib11 article-title: GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health publication-title: J Clin Epidemiol – volume: 169 start-page: 677 year: 2003 end-page: 680 ident: bib4 article-title: Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations publication-title: CMAJ – volume: 34 start-page: 631 year: 2012 end-page: 635 ident: bib12 article-title: Assessing evidence in public health: the added value of GRADE publication-title: J Public Health (Oxf) – volume: 66 start-page: 151 year: 2013 end-page: 157 ident: bib8 article-title: GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes publication-title: J Clin Epidemiol – volume: 64 start-page: 380 year: 2011 end-page: 382 ident: bib2 article-title: GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology publication-title: J Clin Epidemiol – volume: 149 start-page: 2 year: 2008 ident: bib5 article-title: GRADE: assessing the quality of evidence for diagnostic recommendations publication-title: ACP J Club – volume: 36 start-page: 666 year: 2007 end-page: 676 ident: bib18 article-title: Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography publication-title: Int J Epidemiol – volume: 4 start-page: e119 issue: 5 year: 2007 ident: 10.1016/j.jclinepi.2018.01.012_bib14 article-title: Transparent development of the WHO rapid advice guidelines publication-title: PLoS Med doi: 10.1371/journal.pmed.0040119 – volume: 336 start-page: 1106 year: 2008 ident: 10.1016/j.jclinepi.2018.01.012_bib7 article-title: Grading quality of evidence and strength of recommendations for diagnostic tests and strategies publication-title: BMJ doi: 10.1136/bmj.39500.677199.AE – volume: 69 start-page: 189 year: 2015 ident: 10.1016/j.jclinepi.2018.01.012_bib20 article-title: How do systematic reviews incorporate risk of bias assessments into the synthesis of evidence? A methodological study publication-title: J Epidemiol Community Health doi: 10.1136/jech-2014-204711 – volume: 166 start-page: 1399 year: 2002 ident: 10.1016/j.jclinepi.2018.01.012_bib25 article-title: A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals publication-title: CMAJ – volume: 355 start-page: i4919 year: 2016 ident: 10.1016/j.jclinepi.2018.01.012_bib19 article-title: ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions publication-title: BMJ doi: 10.1136/bmj.i4919 – volume: 169 start-page: 677 year: 2003 ident: 10.1016/j.jclinepi.2018.01.012_bib4 article-title: Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations publication-title: CMAJ – volume: 350 start-page: h870 year: 2015 ident: 10.1016/j.jclinepi.2018.01.012_bib15 article-title: Use of GRADE for assessment of evidence about prognosis: rating confidence in estimates of event rates in broad categories of patients publication-title: BMJ doi: 10.1136/bmj.h870 – volume: 36 start-page: 666 year: 2007 ident: 10.1016/j.jclinepi.2018.01.012_bib18 article-title: Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography publication-title: Int J Epidemiol doi: 10.1093/ije/dym018 – volume: 92-93 start-page: 585 year: 2016 ident: 10.1016/j.jclinepi.2018.01.012_bib13 article-title: Using GRADE to respond to health questions with different levels of urgency publication-title: Environ Int doi: 10.1016/j.envint.2016.03.027 – volume: 87 start-page: 14 year: 2017 ident: 10.1016/j.jclinepi.2018.01.012_bib16 article-title: GRADE guidelines 17: assessing the risk of bias associated with missing participant outcome data in a body of evidence publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2017.05.005 – volume: 38 start-page: 39 year: 2017 ident: 10.1016/j.jclinepi.2018.01.012_bib22 article-title: Natural experiments: an overview of methods, approaches, and contributions to public health intervention research publication-title: Annu Rev Public Health doi: 10.1146/annurev-publhealth-031816-044327 – volume: 34 start-page: 631 year: 2012 ident: 10.1016/j.jclinepi.2018.01.012_bib12 article-title: Assessing evidence in public health: the added value of GRADE publication-title: J Public Health (Oxf) doi: 10.1093/pubmed/fds092 – volume: 66 start-page: 151 year: 2013 ident: 10.1016/j.jclinepi.2018.01.012_bib8 article-title: GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2012.01.006 – volume: 64 start-page: 383 year: 2011 ident: 10.1016/j.jclinepi.2018.01.012_bib1 article-title: GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.04.026 – volume: 64 start-page: 380 year: 2011 ident: 10.1016/j.jclinepi.2018.01.012_bib2 article-title: GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2010.09.011 – volume: 328 start-page: 1490 year: 2004 ident: 10.1016/j.jclinepi.2018.01.012_bib21 article-title: Grading quality of evidence and strength of recommendations publication-title: BMJ doi: 10.1136/bmj.328.7454.1490 – volume: 349 start-page: g5630 year: 2014 ident: 10.1016/j.jclinepi.2018.01.012_bib3 article-title: A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis publication-title: BMJ doi: 10.1136/bmj.g5630 – volume: 64 start-page: 1311 year: 2011 ident: 10.1016/j.jclinepi.2018.01.012_bib23 article-title: GRADE guidelines: 9. Rating up the quality of evidence publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2011.06.004 – volume: 87 start-page: 4 year: 2017 ident: 10.1016/j.jclinepi.2018.01.012_bib24 article-title: The GRADE Working Group clarifies the construct of certainty of evidence publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2017.05.006 – volume: 76 start-page: 89 year: 2016 ident: 10.1016/j.jclinepi.2018.01.012_bib11 article-title: GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2016.01.032 – volume: 149 start-page: 2 year: 2008 ident: 10.1016/j.jclinepi.2018.01.012_bib5 article-title: GRADE: assessing the quality of evidence for diagnostic recommendations publication-title: ACP J Club – volume: 345 start-page: e7401 year: 2012 ident: 10.1016/j.jclinepi.2018.01.012_bib6 article-title: Uncertainties in baseline risk estimates and confidence in treatment effects publication-title: BMJ doi: 10.1136/bmj.e7401 – volume: 353 start-page: i2089 year: 2016 ident: 10.1016/j.jclinepi.2018.01.012_bib9 article-title: GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: clinical practice guidelines publication-title: BMJ doi: 10.1136/bmj.i2089 – volume: 92-93 start-page: 611 year: 2016 ident: 10.1016/j.jclinepi.2018.01.012_bib17 article-title: GRADE: assessing the quality of evidence in environmental and occupational health publication-title: Environ Int doi: 10.1016/j.envint.2016.01.004 – volume: 353 start-page: i2016 year: 2016 ident: 10.1016/j.jclinepi.2018.01.012_bib10 article-title: GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction publication-title: BMJ doi: 10.1136/bmj.i2016
SSID	ssj0017075
Score	2.7045293
Snippet	To provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of the risk... AbstractObjectiveTo provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the... ObjectiveTo provide guidance on how systematic review authors, guideline developers, and health technology assessment practitioners should approach the use of...
SourceID	proquest pubmed crossref elsevier
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	105
SubjectTerms	Bias Certainty of the evidence Clinical trials Clinical Trials as Topic - standards Decision making Design Domains Dose-response effects Epidemiology Evidence-Based Medicine - methods Evidence-Based Medicine - standards GRADE Humans Internal Medicine Nonrandomized studies Observational Studies as Topic - standards Practice Guidelines as Topic - standards Quality Quality of evidence Risk Assessment Risk Factors Risk of bias ROBINS Studies Systematic Reviews as Topic Technology assessment Uncertainty Working groups
Title	GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence
URI	https://www.clinicalkey.com/#!/content/1-s2.0-S0895435617310314 https://www.clinicalkey.es/playcontent/1-s2.0-S0895435617310314 https://dx.doi.org/10.1016/j.jclinepi.2018.01.012 https://www.ncbi.nlm.nih.gov/pubmed/29432858 https://www.proquest.com/docview/2236144466 https://www.proquest.com/docview/2001910674
Volume	111
WOSCitedRecordID	wos000472124400012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1878-5921 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1878-5921 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: 7X7 dateStart: 20030101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Healthcare Administration Database customDbUrl: eissn: 1878-5921 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: M0T dateStart: 20030101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthmanagement providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1878-5921 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: 7RV dateStart: 20030101 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1878-5921 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: BENPR dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1878-5921 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: 8C1 dateStart: 20030101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Research Library customDbUrl: eissn: 1878-5921 dateEnd: 20251009 omitProxy: false ssIdentifier: ssj0017075 issn: 0895-4356 databaseCode: M2O dateStart: 20030101 isFulltext: true titleUrlDefault: https://search.proquest.com/pqrl providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagRYgL78JCWQ0S19DYeZoLolVLkei2Wgram-XYDuyqJEu9C4L_wn9lJi-4FBBIkZVkd2wrnow_Z8bzMfYkz0tphbOB4ZySakcy0DzVgShp_kwTF-uGteR1Npnks5k86T64-S6ssreJjaG2taFv5DuCsoTE5H18vvwUEGsUeVc7Co3LbJNos0nPs9mw4OJZm2g3zGUSICxIf9khvHi6oK2Hbjmn8K68Sd3JxUWT00Xgs5mEDm78b_dvsusd_IQXrb7cYpdcdZtdPeoc7HfY95dTHBp4v6bsVxQR_wyw23BYf4Hp8S6u9INXoCsLzb4tWNX1mccSdOM6BopTh7qEYq49zCuoiLugsvXH-Tdnwbchi-A_EK02FA7WHm-jOKWrAKwRTBugsPpKtWgoatucuY769C57e7B_uncYdAwOgUGYsgoQzKRCJzKKnHTaJZmIHAI8G4vCuiQteFSmlKAf9UWLsEySSEtbOBuaPC1t4qIttoFddfcZSJPGTuiiwH_EEtftJi1NUpZSGERwxo5Y0g-dMl16c2LZOFN9HNtC9UOuaMhVyPEQI7YzyC3bBB9_lMh6zVD99lU0uArnoH-TdL6zG15x5YUK1RtSWdJYnhEPHI9HTA6SHTRqIc9ftbrdq6QaGvqpjyP2ePgZTQv5i3Tl6rUnhlJczSOcwebvtWo_PCIh40jkSf7g95U_ZNewJ7KNb95mG6vztXvErpjPq7k_H-PbOn03bt7ZpsyxzPf4mG3u7k9Opnh1FJ5SKY5_AGaCTco
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9NAEF6VgoAX7iNQYJDg0dReH_EiIcRVEjUJqA1S35b17hoSFTt0E6ryX_gL_EZmfMFLASH1ASmyIju762zmcmbm-xh7kKa5MNwaTwcBgWqHwlNBojyek_9MYhupirVk1J9M0r098XaNfW97YaissrWJlaE2pab_yDc5oYRElH18uvjsEWsUZVdbCo1aLLbt0SE-srknw5f4-z7kfOvV9MXAa1gFPI2uc-mhg024ivFB3gqrbNznocWgw0Q8MzZOsiDMEwKNx--guJ_HcaiEyazxdZrkJrYhznuKnSZcPcLqH_vTLmvRr4F9_VTEHoYhyS8dyfNHc2p1tIsZlZOlFVRowI9zhscFu5XT27r4v23XJXahCa_hWa0Pl9maLa6ws-OmgOAq-_Z6B0UPPqwI3Ysq_h8DbhMMykPYefN8ONn1hqAKA1VfGizLct_hEVSVGgeqw4cyh2ymHMwKKIiboTDlp9lXa8DVJZngPhJtOGQWVg5P43CC4wCcEXRdgLE8olkUZKWp3tmG2vUae3cim3OdreOt2psMhE4iy1WW4ScikaapTnId57ngGiNUbXosbkVF6ga-nVhE9mVbpzeXrYhJEjHpB_jiPbbZjVvUACZ_HNFvJVG27bnoUCT62H8baV1jF50MpOPSl7ukIqQhQZ947oKox0Q3sgn96pDur1bdaFVAdgv9lP8eu99dRtNJ-TBV2HLliIE1EAShiMvfqNWs2yIuopCncXrr95PfY-cG0_FIjoaT7dvsPN6VqGu5N9j68mBl77Az-sty5g7uVpYC2PuT1rUfOgKk3g
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3bbtNAEF2VFFW8cL8ECgwSPJrE6-siIURpQ6OWEKVU6tuy3l23iYod6oSq_As_wtcx4xu8FBBSH5AiK7Kzu85mbs7MnMPY0zhOheHWONp1CVTbE45yQ-XwlPxnGFhflawlu9FoFB8ciPEK-970wlBZZWMTS0Ntck3_kfc4oYT4lH3spXVZxHhz8Gr-2SEGKcq0NnQalYjs2LNTfHwrXg438bd-xvlg68ObbadmGHA0utGFg8425CrAh3orrLJBxD2LAYjxeWJsECaul4YEII_fR_F-GgSeEiaxpq_jMDWB9XDeS2w1wiDD77DVja3ReNLmMKIK5rcfi8DBoCT8pT959nxGjY92PqXisrgEDnX5ea7xvNC3dIGDa__z5l1nV-vAG15XmnKDrdjsJlt7V5cW3GLf3k5QKOFwSbhf1AvwAnDLYDs_hcn7jeFozxmCygyUHWuwyPPjAo-gyqQ5UIU-5CkkU1XANIOMWBsyk3-afrUGiqpYE4ojIhSHxMKywNM4nIA6AGcEXZVmLM5oFgVJbsp3tiZ9vc32L2Rz7rAO3qq9x0Do0LdcJQl-whdxHOsw1UGaCq4xdtWmy4JGbKSugd2JX-RYNhV8M9mImyRxk30XX7zLeu24eQVt8scRUSOVsmncRVcj0fv-20hb1BazkK4suOzLPVIX0hY3IgY81-8y0Y6sg8Iq2PurVdcbdZDtQj91ocuetJfRqFKmTGU2XxbEzeoKAlfE5e9WKtduERe-x-Mgvv_7yR-zNVQxuTsc7TxgV_CmRFXkvc46i5Olfcgu6y-LaXHyqDYbwD5etLL9AMp8rvU
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GRADE+guidelines%3A+18.+How+ROBINS-I+and+other+tools+to+assess+risk+of+bias+in+nonrandomized+studies+should+be+used+to+rate+the+certainty+of+a+body+of+evidence&rft.jtitle=Journal+of+clinical+epidemiology&rft.au=Sch%C3%BCnemann%2C+Holger+J&rft.au=Cuello%2C+Carlos&rft.au=Akl%2C+Elie+A&rft.au=Mustafa%2C+Reem+A&rft.date=2019-07-01&rft.issn=1878-5921&rft.eissn=1878-5921&rft.volume=111&rft.spage=105&rft_id=info:doi/10.1016%2Fj.jclinepi.2018.01.012&rft.externalDBID=NO_FULL_TEXT
thumbnail_m	http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F08954356%2FS0895435619X00049%2Fcov150h.gif